Bank Of Nova Scotia Integra Lifesciences Holdings Corp Transaction History

Bank Of Nova Scotia

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$37.95 - $58.98 $3.45 Million - $5.36 Million	90,888 New	90,888 $3.74 Million
Q4 2022 Feb 09, 2023	SELL	$42.17 - $58.6 $1.4 Million - $1.95 Million	-33,300 Reduced 12.99%	223,000 $12.5 Million
Q3 2022 Nov 10, 2022	BUY	$42.28 - $57.17 $10.8 Million - $14.7 Million	256,300 New	256,300 $10.9 Million
Q2 2022 Aug 05, 2022	SELL	$53.86 - $66.52 $2.02 Million - $2.5 Million	-37,567 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$62.86 - $69.24 $188,580 - $207,719	-3,000 Reduced 7.4%	37,567 $2.41 Million
Q4 2021 Feb 11, 2022	SELL	$62.47 - $73.25 $5.18 Million - $6.07 Million	-82,901 Reduced 67.14%	40,567 $2.72 Million
Q3 2021 Nov 12, 2021	BUY	$64.97 - $76.19 $2.35 Million - $2.76 Million	36,239 Added 41.54%	123,468 $8.46 Million
Q2 2021 Aug 12, 2021	BUY	$66.79 - $76.63 $5.83 Million - $6.68 Million	87,229 New	87,229 $5.95 Million

255

75.5M

10.7K

57.7K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.49B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.